Goldman Sachs’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.8M | Buy |
598,528
+138,806
| +30% | +$2.78M | ﹤0.01% | 3012 |
|
|
2025
Q4 | $10.8M | Buy |
459,722
+34,806
| +8% | +$755K | ﹤0.01% | 3028 |
|
|
2025
Q3 | $8.48M | Buy |
424,916
+134,339
| +46% | +$2.41M | ﹤0.01% | 3132 |
|
|
2025
Q2 | $3.98M | Buy |
290,577
+6,243
| +2% | +$59.9K | ﹤0.01% | 3620 |
|
|
2025
Q1 | $3.14M | Sell |
284,334
-33,188
| -10% | -$354K | ﹤0.01% | 3795 |
|
|
2024
Q4 | $3.38M | Buy |
317,522
+1,565
| +0.5% | +$18.7K | ﹤0.01% | 3830 |
|
|
2024
Q3 | $4.01M | Buy |
315,957
+52,351
| +20% | +$777K | ﹤0.01% | 3543 |
|
|
2024
Q2 | $4.42M | Buy |
263,606
+149,744
| +132% | +$2.13M | ﹤0.01% | 3267 |
|
|
2024
Q1 | $1.71M | Sell |
113,862
-359
| -0.3% | -$5.87K | ﹤0.01% | 3975 |
|
|
2023
Q4 | $1.71M | Buy |
114,221
+60,574
| +113% | +$786K | ﹤0.01% | 4036 |
|
|
2023
Q3 | $752K | Buy |
53,647
+22,264
| +71% | +$357K | ﹤0.01% | 4435 |
|
|
2023
Q2 | $325K | Sell |
31,383
-39,172
| -56% | -$432K | ﹤0.01% | 4977 |
|
|
2023
Q1 | $652K | Buy |
70,555
+47,080
| +201% | +$433K | ﹤0.01% | 4674 |
|
|
2022
Q4 | $208K | Sell |
23,475
-117
| -0.5% | -$1.11K | ﹤0.01% | 5285 |
|
|
2022
Q3 | $196K | Sell |
23,592
-14,643
| -38% | -$121K | ﹤0.01% | 5495 |
|
|
2022
Q2 | $313K | Sell |
38,235
-11,495
| -23% | -$78.9K | ﹤0.01% | 5400 |
|
|
2022
Q1 | $434K | Sell |
49,730
-4,243
| -8% | -$33.1K | ﹤0.01% | 5411 |
|
|
2021
Q4 | $513K | Sell |
53,973
-3,207
| -6% | -$45.2K | ﹤0.01% | 5366 |
|
|
2021
Q3 | $962K | Sell |
57,180
-11,851
| -17% | -$188K | ﹤0.01% | 4778 |
|
|
2021
Q2 | $1.05M | Sell |
69,031
-34,368
| -33% | -$621K | ﹤0.01% | 4717 |
|
|
2021
Q1 | $2.01M | Sell |
103,399
-71,893
| -41% | -$1.53M | ﹤0.01% | 3975 |
|
|
2020
Q4 | $3.16M | Buy |
175,292
+15,706
| +10% | +$329K | ﹤0.01% | 3375 |
|
|
2020
Q3 | $3.08M | Buy |
159,586
+16,321
| +11% | +$370K | ﹤0.01% | 3264 |
|
|
2020
Q2 | $3.74M | Buy |
143,265
+23,728
| +20% | +$580K | ﹤0.01% | 3003 |
|
|
2020
Q1 | $2.13M | Buy |
119,537
+25,562
| +27% | +$691K | ﹤0.01% | 3251 |
|
|
2019
Q4 | $3.14M | Sell |
93,975
-32,749
| -26% | -$894K | ﹤0.01% | 3320 |
|
|
2019
Q3 | $3.02M | Buy |
126,724
+69,077
| +120% | +$2.26M | ﹤0.01% | 3231 |
|
|
2019
Q2 | $2.07M | Sell |
57,647
-1,798
| -3% | -$66.3K | ﹤0.01% | 3528 |
|
|
2019
Q1 | $2.2M | Buy |
59,445
+43,266
| +267% | +$1.81M | ﹤0.01% | 3580 |
|
|
2018
Q4 | $697K | Buy |
16,179
+3,945
| +32% | +$177K | ﹤0.01% | 4185 |
|
|
2018
Q3 | $578K | Sell |
12,234
-2,938
| -19% | -$137K | ﹤0.01% | 4351 |
|
|
2018
Q2 | $755K | Sell |
15,172
-29,527
| -66% | -$1.72M | ﹤0.01% | 4259 |
|
|
2018
Q1 | $2.22M | Buy |
44,699
+38,399
| +610% | +$1.92M | ﹤0.01% | 3525 |
|
|
2017
Q4 | $234K | Buy |
+6,300
| New | +$224K | ﹤0.01% | 5334 |
|
Other funds holding URGN
RI
KCM
JFG
PBA
ACA
